Geburtsdatum
Alter
15.07.1992 (Alter: 31)
31
(15.07.1992)
Draft
Saison 14 / #23 (CLE)
Saison 14 / #23
(CLE)
Team
Boston Celtics
Celtics
Career Earnings
360.80 Mio
Gesamt
TOT
18
13075
7029
2288
1092
479
157
374
1816
1816
949
2219
564
650
403
630
1166
493
376
24
15
0
6311
Schnitt
AVG
26.5
14.3
4.6
2.2
1.0
0.3
0.8
3.7
7.0
1.9
4.5
1.1
1.3
0.8
1.3
2.4
52.9%
42.8%
86.8%
27.4
20.9
1.3
0.8
0.0
12.8
20.7%
17.9
2.9
0.76
0.25
Career High
High
36
55
12
8
4
5
5
12
24
15
22
8
10
5
6
39
Gesamt
TOT
10
1065
631
155
85
28
12
36
0
94
94
194
69
77
21
39
-61
39
21
0
1
0
549
Schnitt
AVG
27.3
16.2
4.0
2.2
0.7
0.3
0.9
3.6
7.3
2.4
5.0
1.8
2.0
0.5
1.0
-1.6
49.1%
48.5%
89.6%
3.9
2.1
0.0
0.1
0.0
14.1
0.0%
18.4
0.0
0.00
0.00
Career High
High
32
22
7
5
2
1
2
5
11
4
7
9
10
2
2
18
Gesamt
TOT
1176
622
231
139
42
17
42
219
395
46
109
50
71
46
63
235
42
42
4
1
0
577
Schnitt
AVG
28.0
14.8
5.5
3.3
1.0
0.4
1.0
5.2
9.4
1.1
2.6
1.2
1.7
1.1
1.5
5.6
55.4%
42.2%
70.4%
13.7
22.0%
18.9
3.31
0.67
0.27
Season High
High
33
31
10
7
3
2
4
11
18
4
6
4
6
4
5
30
87.5%
75.0%
75.0%
26
37.1%
38.8
7.00
2.00
1.00
38
83
CLE
11.0
29.1
8.2
3.9
1.6
1.3
0.1
0.6
1.7
3.4
1.4
3.7
0.7
0.8
0.4
1.2
-0.9
49.2%
37.9%
85.7%
18
18
0
0
0
8.0
12.6%
10.1
2.80
1.05
0.09
37
81
IND
26.0
28.2
10.2
3.8
1.9
1.0
0.0
0.9
2.5
3.9
1.5
3.2
0.5
0.7
1.0
1.2
-2.4
64.7%
48.2%
82.4%
26
24
1
0
0
8.3
12.9%
13.9
2.17
0.90
0.00
36
82
IND
26.0
26.4
21.9
4.3
1.7
0.5
0.1
0.5
4.5
9.0
3.1
6.4
3.4
3.7
0.9
1.7
1.3
50.2%
49.1%
93.0%
27
27
1
1
0
17.6
28.5%
25.0
3.29
0.28
0.06
35
82
IND
26.0
21.9
9.2
3.6
2.0
0.9
0.0
1.0
2.2
4.6
1.2
3.0
1.1
1.5
0.6
0.8
5.1
49.2%
40.7%
76.7%
29
0
2
0
0
9.1
17.9%
13.7
2.04
1.04
0.00
34
85
TOR
26.0
25.6
17.8
4.0
2.5
0.9
0.4
0.9
4.7
8.6
2.5
4.8
0.9
1.0
0.6
0.8
-1.8
54.1%
52.6%
88.9%
28
10
3
0
0
14.8
26.4%
22.9
2.76
1.09
0.43
33
85
TOR
26.0
26.8
14.0
4.2
1.8
0.8
0.2
0.6
3.9
8.0
1.9
4.8
0.4
0.4
1.0
0.7
1.9
48.5%
39.7%
100.0%
25
26
2
0
0
13.7
23.1%
15.4
2.88
1.12
0.29
32
85
LAC
25.0
25.8
23.9
3.4
1.8
0.7
0.4
0.8
3.7
6.2
5.0
8.4
1.6
1.6
0.4
1.3
16.2
59.4%
59.8%
97.5%
25
25
2
0
0
16.1
27.0%
30.8
2.30
0.52
0.27
31
84
POR
25.0
29.5
14.9
4.1
2.7
1.0
0.1
0.7
4.5
7.9
1.5
4.5
1.4
1.4
0.8
1.5
-0.8
57.0%
32.8%
97.4%
27
27
2
0
0
13.8
20.0%
16.1
3.65
0.68
0.10
30
85
DAL
25.0
27.6
16.5
5.5
2.5
1.0
0.5
1.0
4.5
8.5
2.2
6.1
1.0
1.3
0.9
1.5
-1.3
52.3%
36.1%
78.8%
26
27
2
2
0
16.1
26.0%
18.0
2.60
0.66
0.32
29
85
MIL
25.0
27.9
18.0
6.5
2.5
1.0
0.3
0.7
3.8
7.8
3.1
7.8
1.1
1.2
1.0
1.5
2.3
49.0%
39.4%
90.9%
45
45
3
5
0
16.8
22.0%
20.1
3.50
0.71
0.23
28
86
BOS
25.0
26.1
15.8
4.7
1.5
0.9
0.8
0.6
3.6
6.2
2.7
6.4
0.7
0.8
0.4
1.3
7.9
58.1%
42.2%
87.5%
40
39
2
0
0
13.6
24.0%
19.8
2.50
0.69
0.62
27
82
ORL
12.0
28.0
14.8
5.5
3.3
1.0
0.4
1.0
5.2
9.4
1.1
2.6
1.2
1.7
1.1
1.5
5.6
55.4%
42.2%
70.4%
42
42
4
1
0
13.7
22.0%
18.9
3.31
0.67
0.27
26
82
ORL
12.0
30.1
18.4
5.7
3.1
1.5
0.5
1.1
5.6
10.8
1.7
3.7
2.1
2.3
1.6
1.8
1.0
51.8%
45.9%
90.8%
33
0
0
4
0
16.6
24.0%
21.3
2.83
0.85
0.29
25
78
ORL
12.0
26.2
8.0
5.4
3.2
1.0
0.4
0.7
3.2
5.9
0.2
1.1
1.0
1.3
1.0
1.4
-1.2
54.2%
17.2%
76.5%
26
28
0
0
0
8.3
9.0%
13.4
4.61
0.72
0.28
24
80
SAC
12.0
28.9
10.7
5.7
2.0
1.4
0.4
0.6
3.8
7.2
0.5
1.9
1.6
1.7
1.1
1.1
1.7
52.8%
27.6%
92.3%
15
0
0
1
0
10.5
13.0%
14.5
3.33
1.24
0.35
23
78
CLE
15.4
14.5
5.2
1.8
0.5
0.5
0.3
0.2
1.3
2.2
0.7
1.3
0.5
0.7
0.3
1.3
-1.5
61.5%
50.0%
75.0%
6
0
0
0
0
4.0
1.0%
13.1
3.00
0.38
0.25
21
79
DEN
8.0
20.0
4.9
2.2
1.7
0.7
0.3
0.7
1.2
3.4
0.7
3.3
0.4
0.5
0.2
0.9
-4.0
34.7%
22.0%
78.6%
28
11
0
0
0
7.5
0.0%
5.1
2.53
0.76
0.28
20
80
GSW
8.0
25.7
10.1
5.3
1.3
1.3
0.2
0.4
2.8
5.3
1.4
2.6
0.5
0.5
0.8
1.1
5.6
52.4%
53.6%
92.9%
27
27
0
1
0
8.5
0.0%
15.5
2.92
1.13
0.20
2022-06-10
06-10
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2022-06-10
06-10
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2022-06-10
06-10
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2022-05-23
05-23
ORL
SAS
30
24
6
4
3
1
3
9
13
2
4
0
0
2
4
19
64.7%
50.0%
--
x
x
20
30.1%
29.4
1.33
0.75
0.25
2022-05-23
05-23
ORL
SAS
30
24
6
4
3
1
3
9
13
2
4
0
0
2
4
19
64.7%
50.0%
--
x
x
20
30.1%
29.4
1.33
0.75
0.25
2022-05-22
05-22
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2022-05-22
05-22
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2022-05-22
05-22
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2022-05-22
05-22
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2022-05-22
05-22
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2022-05-22
05-22
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2022-05-15
05-15
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2022-05-15
05-15
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2022-05-15
05-15
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2022-05-09
05-09
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2022-05-09
05-09
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2022-05-09
05-09
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2022-05-01
05-01
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2022-05-01
05-01
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2022-05-01
05-01
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2022-05-01
05-01
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2022-05-01
05-01
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2022-05-01
05-01
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2022-04-30
04-30
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2022-04-30
04-30
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2022-04-30
04-30
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2022-04-24
04-24
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2022-04-24
04-24
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2022-04-24
04-24
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2022-04-17
04-17
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2022-04-17
04-17
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2022-04-17
04-17
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2022-04-10
04-10
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2022-04-10
04-10
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2022-04-10
04-10
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2022-04-09
04-09
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2022-04-09
04-09
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2022-04-09
04-09
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2022-04-09
04-09
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2022-04-09
04-09
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2022-04-09
04-09
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2022-04-07
04-07
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2022-04-07
04-07
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2022-04-07
04-07
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2022-04-07
04-07
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2022-04-07
04-07
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2022-04-07
04-07
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2022-04-03
04-03
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2022-04-03
04-03
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2022-04-03
04-03
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2022-04-02
04-02
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2022-04-02
04-02
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2022-04-02
04-02
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2022-03-27
03-27
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2022-03-27
03-27
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2022-03-27
03-27
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2022-03-27
03-27
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2022-03-27
03-27
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2022-03-27
03-27
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2022-03-26
03-26
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2022-03-26
03-26
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2022-03-26
03-26
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2022-03-25
03-25
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2022-03-25
03-25
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2022-03-25
03-25
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2022-03-21
03-21
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2022-03-21
03-21
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2022-03-21
03-21
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2022-03-20
03-20
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2022-03-20
03-20
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2022-03-20
03-20
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2022-03-19
03-19
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2022-03-19
03-19
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2022-03-19
03-19
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2022-03-19
03-19
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2022-03-19
03-19
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2022-03-19
03-19
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2022-03-19
03-19
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2022-03-19
03-19
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2022-03-19
03-19
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2022-03-19
03-19
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2022-01-14
01-14
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2022-01-14
01-14
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2022-01-14
01-14
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2022-01-12
01-12
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2022-01-12
01-12
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2022-01-12
01-12
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2022-01-12
01-12
ORL
LAC
29
17
2
2
1
1
2
7
12
0
3
3
4
1
1
-12
46.7%
0.0%
75.0%
x
19
26.8%
14.4
1.00
1.00
1.00
2022-01-12
01-12
ORL
LAC
29
17
2
2
1
1
2
7
12
0
3
3
4
1
1
-12
46.7%
0.0%
75.0%
x
19
26.8%
14.4
1.00
1.00
1.00
2022-01-03
01-03
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2022-01-03
01-03
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2022-01-03
01-03
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2021-12-26
12-26
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2021-12-26
12-26
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2021-12-26
12-26
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2021-12-23
12-23
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2021-12-23
12-23
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2021-12-23
12-23
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2021-11-27
11-27
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2021-11-27
11-27
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2021-11-27
11-27
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2021-11-13
11-13
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2021-11-13
11-13
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2021-11-13
11-13
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2021-11-09
11-09
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2021-11-09
11-09
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2021-11-09
11-09
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2021-11-08
11-08
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2021-11-08
11-08
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2021-11-08
11-08
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2021-10-31
10-31
ORL
HOU
28
12
3
3
0
0
1
5
8
0
1
2
2
0
1
10
55.6%
0.0%
100.0%
x
11
16.4%
13.2
3.00
0.00
0.00
2021-10-31
10-31
ORL
HOU
28
12
3
3
0
0
1
5
8
0
1
2
2
0
1
10
55.6%
0.0%
100.0%
x
11
16.4%
13.2
3.00
0.00
0.00
2021-10-30
10-30
ORL
SAS
30
24
6
4
3
1
3
9
13
2
4
0
0
2
4
19
64.7%
50.0%
--
x
x
20
30.1%
29.4
1.33
0.75
0.25
2021-10-30
10-30
ORL
SAS
30
24
6
4
3
1
3
9
13
2
4
0
0
2
4
19
64.7%
50.0%
--
x
x
20
30.1%
29.4
1.33
0.75
0.25
2021-10-30
10-30
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2021-10-30
10-30
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2021-10-30
10-30
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2021-10-23
10-23
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2021-10-23
10-23
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2021-10-23
10-23
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2021-10-21
10-21
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2021-10-21
10-21
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2021-10-21
10-21
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2021-10-21
10-21
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2021-10-18
10-18
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2021-10-18
10-18
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2021-10-18
10-18
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2021-10-14
10-14
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2021-10-14
10-14
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2021-10-14
10-14
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2021-10-13
10-13
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2021-10-13
10-13
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2021-10-13
10-13
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2021-10-12
10-12
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2021-10-12
10-12
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2021-10-12
10-12
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2021-10-10
10-10
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2021-10-10
10-10
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2021-10-10
10-10
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2021-10-09
10-09
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2021-10-09
10-09
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2021-10-09
10-09
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2021-10-06
10-06
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2021-10-06
10-06
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2021-10-06
10-06
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2021-10-05
10-05
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2021-10-05
10-05
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2021-10-05
10-05
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2021-10-04
10-04
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2021-10-04
10-04
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2021-10-04
10-04
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2021-10-04
10-04
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2021-10-04
10-04
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2021-10-04
10-04
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2021-10-03
10-03
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2021-10-03
10-03
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2021-10-03
10-03
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2021-10-03
10-03
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2021-10-03
10-03
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2021-10-03
10-03
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2021-10-02
10-02
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2021-10-02
10-02
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2021-10-02
10-02
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2021-10-02
10-02
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2021-10-02
10-02
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2021-10-02
10-02
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2019-02-03
02-03
ORL
BKN
23
6
3
1
1
0
1
3
8
0
0
0
0
1
1
21
37.5%
--
--
x
9
0.0%
5.4
1.00
1.00
0.00
2019-02-03
02-03
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2019-02-03
02-03
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2019-02-03
02-03
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2019-02-03
02-03
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2019-02-03
02-03
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2019-02-03
02-03
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2019-02-02
02-02
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2019-02-02
02-02
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2019-02-02
02-02
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2019-02-02
02-02
ORL
NYK
30
20
2
0
0
0
0
4
4
4
6
0
0
0
0
-7
80.0%
66.7%
--
x
10
14.9%
23.5
--
--
--
2019-02-01
02-01
ORL
TOR
31
19
6
3
1
0
1
6
12
1
1
4
4
4
2
-6
53.8%
100.0%
100.0%
x
16
19.7%
23.2
3.00
0.50
0.00
2019-02-01
02-01
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2019-02-01
02-01
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2019-02-01
02-01
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2019-01-30
01-30
ORL
SAS
30
24
6
4
3
1
3
9
13
2
4
0
0
2
4
19
64.7%
50.0%
--
x
x
20
30.1%
29.4
1.33
0.75
0.25
2019-01-30
01-30
ORL
SAS
30
24
6
4
3
1
3
9
13
2
4
0
0
2
4
19
64.7%
50.0%
--
x
x
20
30.1%
29.4
1.33
0.75
0.25
2019-01-30
01-30
ORL
MIL
31
17
9
6
1
0
1
7
12
1
3
0
0
1
1
15
53.3%
33.3%
--
x
16
22.0%
21.8
6.00
1.00
0.00
2019-01-27
01-27
ORL
ATL
29
13
5
3
0
0
2
5
12
1
4
0
0
1
0
8
37.5%
25.0%
--
x
18
25.8%
7.7
1.50
--
--
2019-01-27
01-27
ORL
HOU
28
12
3
3
0
0
1
5
8
0
1
2
2
0
1
10
55.6%
0.0%
100.0%
x
11
16.4%
13.2
3.00
0.00
0.00
2019-01-27
01-27
ORL
HOU
28
12
3
3
0
0
1
5
8
0
1
2
2
0
1
10
55.6%
0.0%
100.0%
x
11
16.4%
13.2
3.00
0.00
0.00
2019-01-12
01-12
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2019-01-12
01-12
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2019-01-12
01-12
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2019-01-12
01-12
ORL
MIA
25
16
4
3
2
0
0
5
8
2
3
0
0
0
0
17
63.6%
66.7%
--
x
11
22.5%
27.3
--
--
--
2019-01-11
01-11
ORL
PHI
29
16
8
4
0
0
0
5
6
2
2
0
0
0
1
17
87.5%
100.0%
--
x
8
12.5%
26.0
--
0.00
0.00
2019-01-11
01-11
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2019-01-11
01-11
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2019-01-11
01-11
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2019-01-06
01-06
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2019-01-06
01-06
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2019-01-06
01-06
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2019-01-06
01-06
ORL
CLE
23
15
2
3
0
0
1
4
8
1
3
4
4
1
1
21
45.5%
33.3%
100.0%
x
14
28.5%
18.9
3.00
0.00
0.00
2018-12-21
12-21
ORL
WAS
33
12
6
2
2
2
2
6
14
0
3
0
0
0
3
-6
35.3%
0.0%
--
x
19
24.1%
6.8
1.00
0.67
0.67
2018-12-13
12-13
ORL
DET
30
10
5
4
3
0
1
2
3
1
5
3
4
0
5
3
37.5%
20.0%
75.0%
x
11
16.0%
13.0
4.00
0.60
0.00
2018-12-10
12-10
ORL
IND
27
13
5
3
0
1
1
5
13
1
3
0
0
4
3
-11
37.5%
33.3%
--
x
17
29.7%
11.9
3.00
0.00
0.33
2018-12-10
12-10
ORL
IND
27
13
5
3
0
1
1
5
13
1
3
0
0
4
3
-11
37.5%
33.3%
--
x
17
29.7%
11.9
3.00
0.00
0.33
2018-12-08
12-08
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2018-12-08
12-08
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2018-12-08
12-08
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2018-12-07
12-07
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2018-12-07
12-07
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2018-12-07
12-07
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2018-12-01
12-01
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2018-12-01
12-01
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2018-12-01
12-01
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2018-12-01
12-01
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2018-12-01
12-01
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2018-12-01
12-01
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2018-11-30
11-30
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2018-11-30
11-30
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2018-11-30
11-30
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2018-11-28
11-28
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2018-11-28
11-28
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2018-11-28
11-28
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2018-11-26
11-26
ORL
CHA
29
13
6
4
1
0
1
5
7
1
1
0
0
1
1
16
75.0%
100.0%
--
x
9
12.6%
20.8
4.00
1.00
0.00
2018-11-25
11-25
ORL
CHI
32
15
9
2
1
1
0
6
10
1
3
0
0
4
0
1
53.8%
33.3%
--
x
13
18.2%
21.1
--
--
--
2018-11-24
11-24
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2018-11-24
11-24
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2018-11-24
11-24
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2018-11-24
11-24
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2018-11-21
11-21
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2018-11-21
11-21
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2018-11-21
11-21
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2018-11-20
11-20
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2018-11-20
11-20
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2018-11-20
11-20
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2018-11-11
11-11
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2018-11-11
11-11
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2018-11-11
11-11
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2018-11-10
11-10
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2018-11-10
11-10
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2018-11-10
11-10
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2018-11-07
11-07
ORL
LAC
29
17
2
2
1
1
2
7
12
0
3
3
4
1
1
-12
46.7%
0.0%
75.0%
x
19
26.8%
14.4
1.00
1.00
1.00
2018-11-07
11-07
ORL
LAC
29
17
2
2
1
1
2
7
12
0
3
3
4
1
1
-12
46.7%
0.0%
75.0%
x
19
26.8%
14.4
1.00
1.00
1.00
2018-11-05
11-05
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2018-11-05
11-05
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2018-11-05
11-05
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2018-11-02
11-02
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2018-11-02
11-02
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2018-11-02
11-02
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2018-10-31
10-31
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2018-10-31
10-31
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2018-10-31
10-31
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2018-10-31
10-31
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2018-10-31
10-31
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2018-10-31
10-31
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2018-10-28
10-28
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2018-10-28
10-28
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2018-10-28
10-28
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2018-10-24
10-24
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2018-10-24
10-24
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2018-10-24
10-24
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2018-10-14
10-14
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2018-10-14
10-14
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2018-10-14
10-14
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2008-10-16
10-16
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2008-10-16
10-16
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2008-10-16
10-16
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00